Alembic receives USFDA final approval for Fulvestrant Injection
Fulvestrant Injection, 250 mg/5 mL, has an estimated market size of US $71 million for twelve months ending Sep 2022 according to IQVIA
Fulvestrant Injection, 250 mg/5 mL, has an estimated market size of US $71 million for twelve months ending Sep 2022 according to IQVIA
Miravo to remain a Canadian controlled and operated company following closing of the transaction
The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
The scheme is subject to statutory and regulatory approvals as may be necessary.
The product is backed by required scientific proof and comparative bioequivalence studies
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
This partnership stemmed from a successful customer-supplier relationship spanning several years.
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
Subscribe To Our Newsletter & Stay Updated